» Articles » PMID: 24554039

Edaravone Protects Endotoxin-induced Liver Injury by Inhibiting Apoptosis and Reducing Proinflammatory Cytokines

Overview
Date 2014 Feb 21
PMID 24554039
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Studies have shown that edaravone may prevent liver injury. This study aimed to investigate the effects of edaravone on the liver injury induced by D-galactosamine (GalN) and lipopolysaccharide (LPS) in female BALB/c mice. Edaravone was injected into mice 30 min before and 4 h after GalN/LPS injection. The survival rate was determined within the first 24 h. Animals were killed 8 h after GalN/LPS injection, and liver injury was biochemically and histologically assessed. Hepatocyte apoptosis was measured by TUNEL staining; proinflammatory cytokines [tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6)] in the liver were assayed by ELISA; expression of caspase-8 and caspase-3 proteins was detected by Western blot assay; and caspase-3 activity was also determined. Results showed that GalN/LPS induced marked elevations in serum aspartate aminotransferase (AST) and alanine aminotransferase (ALT). Edaravone significantly inhibited elevation of serum AST and ALT, accompanied by an improvement in histological findings. Edaravone lowered the levels of TNF-α and IL-6 and reduced the number of TUNEL-positive cells. In addition, 24 h after edaravone treatment, caspase-3 activity and mortality were reduced. Edaravone may effectively ameliorate GalN/LPS-induced liver injury in mice by reducing proinflammatory cytokines and inhibiting apoptosis.

Citing Articles

Excess DHA Induces Liver Injury Lipid Peroxidation and Gut Microbiota-Derived Lipopolysaccharide in Zebrafish.

Ding Q, Hao Q, Zhang Q, Yang Y, Olsen R, Ringo E Front Nutr. 2022; 9:870343.

PMID: 35571918 PMC: 9096794. DOI: 10.3389/fnut.2022.870343.


Quantitative Proteomic Analysis Reveals the Sites Related to Acetylation and Mechanism of ACY-1215 in Acute Liver Failure Mice.

Zhang W, Zhang H, Wang Y, Jiao F, Wang L, Gong Z Front Pharmacol. 2019; 10:653.

PMID: 31244662 PMC: 6581020. DOI: 10.3389/fphar.2019.00653.

References
1.
Schafer T, Scheuer C, Roemer K, Menger M, Vollmar B . Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death. FASEB J. 2003; 17(6):660-7. DOI: 10.1096/fj.02-0774com. View

2.
Chuang C, Chen T, Cherng Y, Tai Y, Chen T, Chen R . Lipopolysaccharide induces apoptotic insults to human alveolar epithelial A549 cells through reactive oxygen species-mediated activation of an intrinsic mitochondrion-dependent pathway. Arch Toxicol. 2010; 85(3):209-18. DOI: 10.1007/s00204-010-0585-x. View

3.
Watanabe K, Ma M, Wen J, Kodama M, Aizawa Y . Effects of edaravone in heart of aged rats after cerebral ischemia-reperfusion injury. Biol Pharm Bull. 2007; 30(3):460-4. DOI: 10.1248/bpb.30.460. View

4.
Bohlinger I, Leist M, Gantner F, Angermuller S, Tiegs G, Wendel A . DNA fragmentation in mouse organs during endotoxic shock. Am J Pathol. 1996; 149(4):1381-93. PMC: 1865174. View

5.
Ito K, Ozasa H, Noda Y, Arii S, Horikawa S . Effects of free radical scavenger on acute liver injury induced by d-galactosamine and lipopolysaccharide in rats. Hepatol Res. 2007; 38(2):194-201. DOI: 10.1111/j.1872-034X.2007.00252.x. View